Children with biliary atresia have substantial morbidity in early childhood and a high risk of liver transplantation

  • Mads Damkjær
  • , Joachim Tan
  • , Maria Loane
  • , Joanne Given
  • , Elisa Ballardini
  • , Clara Cavero‑Carbonell
  • , Gissler Mika
  • , Sue Jordan
  • , Anna Pierini
  • , Anke Rissmann
  • , David Tucker
  • , Ester Garne
  • , Joan K. Morris

Research output: Contribution to journalArticlepeer-review

5 Downloads (Pure)

Abstract

Background:
Biliary atresia is a rare but severe congenital anomaly associated with substantial morbidity and mortality in early childhood. Population-based estimates of survival, surgical management, and liver transplantation across Europe remain limited. This study aimed to describe mortality and morbidity among children born with biliary atresia using multinational population-based data.
Methods:
We investigated children diagnosed with biliary atresia across nine registries from five countries within the European surveillance of congenital anomalies network (EUROCAT), covering births from 1995 to 2014. The data were linked to hospital databases and adjusted for regional differences and follow-up length.
Results:
Our cohort included 171 children, with an infant mortality rate of 12.3% (95% CI: 7.8–17.6) and a mortality rate before age five of 18.5% (95% CI: 10.7–27.7). Among these children, 151 had undergone surgery, including 133 who received the Kasai procedure by the age of 1 year at a median age of 57 days (95% CI: 51–62 days). By age five, 37% (adjusted percentage, 95% CI: 30–44) had undergone liver transplantation, with the median age at transplantation being 318 days (95% CI: 244–391 days). Median age at death in the first year was over 6 months and was not immediately after surgery.
Conclusion:
The high mortality and the substantial need for liver transplantation within the first year of life underline the se-verity of biliary atresia. This highlights the urgent need for further research into pregnancy exposures that may contribute to this rare but severe congenital anomaly to develop primary prevention strategies.
Original languageEnglish
Article numbere70024
Pages (from-to)1-6
Number of pages6
JournalBirth Defects Research
Volume118
Issue number2
Early online date8 Feb 2026
DOIs
Publication statusPublished (in print/issue) - 8 Feb 2026

Bibliographical note

© 2026 Wiley Periodicals LLC.

Data Access Statement

The data that support the findings of this study are available from the participating registries of congenital anomalies, but restrictions apply to the availability of these data, which were used under license for the current study. These data are available for scientifically valid requests and with permission of the participating registries of congenital anomalies. To apply for the data please contact the corresponding author.

Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733001. The funders had no role in the study.

Funder number
733001

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Morbidity
    • Liver transplantation
    • Biliary Atresia
    • Congenital Anomalies
    • Data linkage
    • biliary atresia
    • morbidity
    • liver transplantation
    • Humans
    • Risk Factors
    • Child, Preschool
    • Biliary Atresia/surgery
    • Infant
    • Male
    • Europe/epidemiology
    • Female
    • Registries
    • Infant, Newborn
    • Liver Transplantation/methods

    Fingerprint

    Dive into the research topics of 'Children with biliary atresia have substantial morbidity in early childhood and a high risk of liver transplantation'. Together they form a unique fingerprint.
    • EUROlinkCAT

      Sinclair, M. (CoI) & Loane, M. (PI)

      1/01/1731/05/22

      Project: Research

    Cite this